Optiver Holding
RIGL icon

Optiver Holding’s Rigel Pharmaceuticals RIGL Stock Holding History

Optiver Holding’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.2K Sell
1,309
-458
-26% -$14.1K ﹤0.01% 1157
2026
Q1 		$47.8K Sell
1,767
-132
-7% -$4.44K ﹤0.01% 970
2025
Q4 		$81.3K Buy
1,899
+1,054
+125% +$39.7K ﹤0.01% 834
2025
Q3 		$23.9K Buy
+845
New +$25.3K ﹤0.01% 924

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Optiver Holding's RIGL Position: Q2 2026 in Review

Optiver Holding reduced its Rigel Pharmaceuticals (RIGL) stake by 26% in Q2 2026, selling an estimated $14.1K and leaving 1,309 shares worth $51.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1157.

Optiver Holding first reported a position in RIGL in Q3 2025 and has held it in 4 quarters since. The position peaked at $81.3K in Q4 2025. 155 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • Optiver Holding held 1,309 shares of Rigel Pharmaceuticals worth $51.2K as of Q2 2026.
  • Optiver Holding sold 458 Rigel Pharmaceuticals shares in Q2 2026, an estimated $14.1K.
  • Rigel Pharmaceuticals made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1157 holding.
  • Optiver Holding first reported a position in Rigel Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Rigel Pharmaceuticals position peaked at $81.3K in Q4 2025.
  • 155 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.